---
figid: PMC9553391__OMCL2022-8965903.005
pmcid: PMC9553391
image_filename: OMCL2022-8965903.005.jpg
figure_link: /pmc/articles/PMC9553391/figure/fig5/
number: Figure 5
figure_title: ''
caption: Anlo increased the expression of PDL1 by ROS/JNK/AP-1 pathway in vitro. (a)
  ROS production was determined and analyzed by flow cytometry. (b) Representative
  western blots of HSP90, T-JNK, P-JNK, P-C-FOS, P-C-JUN, IFN-α, IFN-β, and IFN-γ.
  (c) The expression of mRNA levels of IFN-α, IFN-β, and IFN-γ. (d) RNA sequence data
  analysis of CT26 tumor.
article_title: Anlotinib Benefits the αPDL1 Immunotherapy by Activating ROS/JNK/AP-1
  Pathway to Upregulate PDL1 Expression in Colorectal Cancer.
citation: Bixian Luo, et al. Oxid Med Cell Longev. 2022;2022:8965903.
year: '2022'

doi: 10.1155/2022/8965903
journal_title: Oxidative Medicine and Cellular Longevity
journal_nlm_ta: Oxid Med Cell Longev
publisher_name: Hindawi

keywords:
---
